446 related articles for article (PubMed ID: 23723452)
21. Variant RH alleles and Rh immunisation in patients with sickle cell disease.
Sippert E; Fujita CR; Machado D; Guelsin G; Gaspardi AC; Pellegrino J; Gilli S; Saad SS; Castilho L
Blood Transfus; 2015 Jan; 13(1):72-7. PubMed ID: 24960646
[TBL] [Abstract][Full Text] [Related]
22. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.
Gaspardi AC; Sippert EA; De Macedo MD; Pellegrino J; Costa FF; Castilho L
Blood Transfus; 2016 Sep; 14(5):449-54. PubMed ID: 27177398
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
24. Alloimmunization in transfused patients with constitutional anemias in Norway.
Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
[TBL] [Abstract][Full Text] [Related]
25. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
[TBL] [Abstract][Full Text] [Related]
26. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
Leiva-Torres GA; Cigna M; Constanzo-Yanez J; St-Louis M; Perreault J; Lavoie J; Laflamme G; Lewin A; Pastore Y; Robitaille N
Transfusion; 2024 Apr; 64(4):716-726. PubMed ID: 38497419
[TBL] [Abstract][Full Text] [Related]
27. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
Lasalle-Williams M; Nuss R; Le T; Cole L; Hassell K; Murphy JR; Ambruso DR
Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
29. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Ameen R; Al Shemmari S; Al-Bashir A
Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
[TBL] [Abstract][Full Text] [Related]
30. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
Allali S; Peyrard T; Amiranoff D; Cohen JF; Chalumeau M; Brousse V; de Montalembert M
Br J Haematol; 2017 May; 177(4):641-647. PubMed ID: 28402005
[TBL] [Abstract][Full Text] [Related]
32. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
[TBL] [Abstract][Full Text] [Related]
33. How do I incorporate red cell genotyping to improve chronic transfusion therapy?
Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM
Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485
[TBL] [Abstract][Full Text] [Related]
35. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
[TBL] [Abstract][Full Text] [Related]
37. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
[TBL] [Abstract][Full Text] [Related]
38. In search of red blood cells for alloimmunized patients with sickle cell disease.
Flickinger C
Immunohematology; 2006; 22(3):136-42. PubMed ID: 17105363
[TBL] [Abstract][Full Text] [Related]
39. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
Friedman DF; Lukas MB; Jawad A; Larson PJ; Ohene-Frempong K; Manno CS
Blood; 1996 Oct; 88(8):3216-22. PubMed ID: 8874223
[TBL] [Abstract][Full Text] [Related]
40. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
